Poor Economy Prompts Some To Cut Back on Rx Drugs
In response to the economic downturn, some U.S. consumers are cutting back on prescription drugs. IMS Health found that the number of prescriptions dispensed through August of this year was lower than the first eight months of last year, and Pfizer has reported that sales of its drug Lipitor are down 13% in Q3.
- "Some Cut Back on Prescription Drugs in Sour Economy" (Saul, New York Times, 10/22).